Instil Bio Inc

NASDAQ:TIL   3:59:55 PM EDT
23.27
+0.18 (+0.78%)
Products, Regulatory

Instil Bio Gets Clearance For Phase 2 Trial For Patients With Advanced Melanoma

Published: 09/13/2021 12:57 GMT
Instil Bio Inc (TIL) - Instil Bio Receives Ind Clearance to Initiate a Phase 2 Clinical Trial for Patients With Advanced Melanoma.
Instil Bio Inc - Topline Safety and Efficacy Results Are Expected in 2023.
Instil Bio Inc - Topline Safety and Efficacy Results, If Positive, Are Anticipated to Support Submission of a Bla to FDA in 2023.
Instil Bio Inc -topline Safety and Efficacy Results, If Positive, Are Anticipated to Support Submission of a Maa to European Medicines Agency in 2024.